Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Method and apparatus for treating restless legs syndrome

a technology of restless legs and treatment methods, applied in the field of restless legs syndrome, can solve the problems of uncurative rls drug therapy, side effects, and difficulty in sleeping for many patients, and achieve the effect of reducing and/or preventing on the onset of one or more rls symptoms

Inactive Publication Date: 2016-12-08
INVICTA MEDICAL
View PDF5 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes a system for treating RLS symptoms in patients using electrical stimulation. The system includes a waveform generator and four electrodes that are placed on the patient's lumbar region and right and left legs. The electrodes are designed to stimulate the femoral nerve and reduce or prevent the transmission of signals from the brain to the legs that cause RLS symptoms. The technical effect of the system is to provide a non-invasive and effective treatment for RLS symptoms.

Problems solved by technology

These symptoms of RLS can make sleeping difficult for many patients and a recent poll shows the presence of significant daytime difficulties resulting from this condition.
It is often progressive and gets worse with age.
RLS drug therapy is not curative and has side effects such as nausea, dizziness, hallucinations, orthostatic hypotension, or daytime sleep attacks.
There are, however, issues with the use of dopamine agonists including augmentation.
Dopamine agonists may also cause rebound, when symptoms increase as the drug wears off.
In many cases, the longer dopamine agonists are used the higher the risk of augmentation and rebound as well as the severity of the symptoms.
A recent study has indicated that dopamine agonists used in restless leg syndrome may lead to an increase in compulsive gambling.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and apparatus for treating restless legs syndrome
  • Method and apparatus for treating restless legs syndrome
  • Method and apparatus for treating restless legs syndrome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024]Non-invasive apparatuses and method for treating restless legs syndrome (RLS) are disclosed herein. In the following description, numerous specific details are set forth to provide a thorough understanding of the present disclosure. Also, in the following description and for purposes of explanation, specific nomenclature is set forth to provide a thorough understanding of the present embodiments. However, it will be apparent to one skilled in the art that these specific details may not be required to practice the present embodiments. In other instances, well-known circuits and devices are shown in block diagram form to avoid obscuring the present disclosure. The term “coupled” as used herein means connected directly to or connected through one or more intervening components, circuits, or physiological matter. Any of the signals provided over various buses described herein may be time-multiplexed with other signals and provided over one or more common buses. Additionally, the i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Apparatuses and methods are disclosed that may be used to treat one or more restless leg syndrome (RLS) symptoms of a patient. One example method may include generating first and second stimulation waveforms using a waveform generator; electrically stimulating at least a portion of a sacral region of the patient, based on the first and second stimulation waveforms, using a number of electrodes; damping or interfering with electrical signals transmitted from the patient's brain to the patient's legs via a femoral nerve of the patient using the electrical stimulation; and reducing the one or more symptoms of RLS based on damping or interfering with the electrical signals transmitted from the patient's brain.

Description

CROSS-REFERENCE TO RELATED APPLICATION[0001]This application claims priority to co-pending and commonly owned U.S. Provisional Patent Application No. 62 / 171,218 entitled “METHOD AND APPARATUS FOR TREATING RESTLESS LEGS SYNDROME” filed on Jun. 4, 2015, the entirety of which is incorporated by reference herein.TECHNICAL FIELD[0002]The present embodiments relate generally to restless legs syndrome (RLS), and specifically to non-invasive techniques for treating one or more symptoms of RLS.BACKGROUND OF RELATED ART[0003]Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a neurological disorder characterized by an irresistible urge to move one's body to stop uncomfortable or odd sensations. It most commonly affects the legs, but can affect the arms, torso, and even phantom limbs, RLS sensations range from pain or an aching in the muscles, to an itch you can't scratch,” an unpleasant “tickle that won't stop,” or even a “crawling” feeling. The sensations typically be...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61N1/36A61N1/04
CPCA61N1/36003A61N1/36014A61N1/0484A61N1/0456A61N1/36031A61N1/36034A61N1/3603
Inventor KENT, STEVEN THOMAS
Owner INVICTA MEDICAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products